A Rare Case of Dapagliflozin-Induced Hepatic Toxicity
Abstract Drug-induced liver injury is a challenging clinical condition in terms of both diagnosis and treatment. It presents a wide range of clinical manifestations, and identification of the implicated substance is crucial. Several adverse effects have been described in association with dapagliflozin, but not liver enzyme elevation. The authors present the case of a 71-year-old diabetic woman who developed gastrointestinal symptoms one month after increasing the dose of dapagliflozin. Liver en-zyme elevation was observed, without evidence of obstructive causes on imaging exams. Other causes of liver disease were excluded, and liver biopsy favored a toxic/drug etiology. Liver enzyme normalization was observed after discontinuation of dapagliflozin. Liver injury associated with sodium-glucose co-transporter 2 inhibitors is very rare, and the authors aim to raise awareness about the potential hepatotoxic effects of dapagliflozin, highlighting the importance of early diagnosis and appropriate treatment.
| Main Authors: | , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Sociedade Portuguesa de Medicina Interna
2024
|
| Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-671X2024000400039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|